NIEHS technical report on the reproductive, developmental, and general toxicity studies of 3'-Azido-3'-deoxythymidine (AZT) and clarithromycin combinations (CAS nos. 30516-87-1 and 81103-11-9) administered by Gavage to Swiss cD-1(r) mice
Because of excessive mortality, a second study was conducted using 250, 500, and 1,000 mg/kg purified clarithromycin, equivalent to approximately 1, 2, and 4 times the human therapeutic dose, and 200 and 400 mg/kg AZT, which are approximately 2 and 4 times the human therapeutic dose. The most signif...
| Main Author: | |
|---|---|
| Corporate Author: | |
| Format: | eBook |
| Language: | English |
| Published: |
[Bethesda, Maryland]
U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health
2003, October 2003
|
| Series: | NIEHS AIDS therapeutics toxicity report
|
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
Table of Contents:
- Includes bibliographical references